Peter Svennilson - Net Worth and Insider Trading

Peter Svennilson Net Worth

The estimated net worth of Peter Svennilson is at least $278 Million dollars as of 2024-04-24. Peter Svennilson is the Director of Revolution Medicines Inc and owns about 4,737,523 shares of Revolution Medicines Inc (RVMD) stock worth over $168 Million. Peter Svennilson is the Director, 10% Owner of RAPT Therapeutics Inc and owns about 5,630,497 shares of RAPT Therapeutics Inc (RAPT) stock worth over $45 Million. Peter Svennilson is also the Director, 10% Owner of Immune Design Corp and owns about 6,642,942 shares of Immune Design Corp (IMDZ) stock worth over $39 Million. Besides these, Peter Svennilson also holds NGM Biopharmaceuticals Inc (NGM) . Details can be seen in Peter Svennilson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Svennilson has not made any transactions after 2021-04-28 and currently still holds the listed stock(s).

Transaction Summary of Peter Svennilson

To

Peter Svennilson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Peter Svennilson owns 10 companies in total, including RAPT Therapeutics Inc () , NGM Biopharmaceuticals Inc () , and Nurix Therapeutics Inc () among others .

Click here to see the complete history of Peter Svennilson’s form 4 insider trades.

Insider Ownership Summary of Peter Svennilson

Ticker Comapny Transaction Date Type of Owner
RAPT Therapeutics Inc 2021-08-18 10 percent owner
NGM Biopharmaceuticals Inc 2020-04-08 director & 10 percent owner
Nurix Therapeutics Inc 2021-05-07 10 percent owner
Revolution Medicines Inc 2021-04-28 director & 10 percent owner
ORIC Pharmaceuticals Inc 2021-11-12 10 percent owner
Constellation Pharmaceuticals Inc 2020-03-19 10 percent owner & other: Managing Partner
Gritstone Bio Inc 2018-09-27 director & 10 percent owner
Immune Design Corp 2019-04-02 10 percent owner & other: Managing Partner
Arcus Biosciences Inc 2018-03-14 10 percent owner
eFFECTOR Therapeutics Inc 2021-08-25 10 percent owner

Peter Svennilson Latest Holdings Summary

Peter Svennilson currently owns a total of 4 stocks. Among these stocks, Peter Svennilson owns 4,737,523 shares of Revolution Medicines Inc (RVMD) as of April 28, 2021, with a value of $168 Million and a weighting of 60.22%. Peter Svennilson owns 5,630,497 shares of RAPT Therapeutics Inc (RAPT) as of September 22, 2020, with a value of $45 Million and a weighting of 16%. Peter Svennilson also owns 6,642,942 shares of Immune Design Corp (IMDZ) as of October 27, 2017, with a value of $39 Million and a weighting of 13.97%. The other 1 stocks NGM Biopharmaceuticals Inc (NGM) have a combined weighting of 9.81% among all his current holdings.

Latest Holdings of Peter Svennilson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RVMD Revolution Medicines Inc 2021-04-28 4,737,523 35.37 167,566,189
RAPT RAPT Therapeutics Inc 2020-09-22 5,630,497 7.91 44,509,079
IMDZ Immune Design Corp 2017-10-27 6,642,942 5.85 38,861,211
NGM NGM Biopharmaceuticals Inc 2020-04-08 17,726,978 1.54 27,299,546

Holding Weightings of Peter Svennilson


Peter Svennilson Form 4 Trading Tracker

According to the SEC Form 4 filings, Peter Svennilson has made a total of 4 transactions in Revolution Medicines Inc (RVMD) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Revolution Medicines Inc is the sale of 76,410 shares on April 28, 2021, which brought Peter Svennilson around $3 Million.

According to the SEC Form 4 filings, Peter Svennilson has made a total of 2 transactions in RAPT Therapeutics Inc (RAPT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in RAPT Therapeutics Inc is the sale of 608,000 shares on September 22, 2020, which brought Peter Svennilson around $19 Million.

According to the SEC Form 4 filings, Peter Svennilson has made a total of 0 transactions in Immune Design Corp (IMDZ) over the past 5 years. The most-recent trade in Immune Design Corp is the acquisition of 2,681,000 shares on October 27, 2017, which cost Peter Svennilson around $11 Million.

More details on Peter Svennilson's insider transactions can be found in the Insider Trading History of Peter Svennilson table.

Insider Trading History of Peter Svennilson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Peter Svennilson Trading Performance

GuruFocus tracks the stock performance after each of Peter Svennilson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Svennilson is 19.36%. GuruFocus also compares Peter Svennilson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Svennilson within 3 months outperforms 21 times out of 34 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Peter Svennilson's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Peter Svennilson

Average Return

51.97%

Average return per transaction

Outperforming Transactions

94%

32 out of 34 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 12.49 19.36 22.52 51.97 18.91 -12.16
Relative Return to S&P 500(%) 11.8 12.83 12.59 34.3 -3.91 -23.12

Peter Svennilson Ownership Network

Ownership Network List of Peter Svennilson

No Data

Ownership Network Relation of Peter Svennilson


Peter Svennilson Owned Company Details

What does RAPT Therapeutics Inc do?

Who are the key executives at RAPT Therapeutics Inc?

Peter Svennilson is the 10 percent owner of RAPT Therapeutics Inc. Other key executives at RAPT Therapeutics Inc include Chief Scientific Officer Dirk G. Brockstedt , Chief Medical Officer William Ho , and 10 percent owner Column Group Ii, Lp .

RAPT Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Peter Svennilson made no insider transaction in RAPT Therapeutics Inc (). Other recent insider transactions involving RAPT Therapeutics Inc () include a net sale of 44,000 shares made by William Ho , a net sale of 1,640 shares made by Dirk G. Brockstedt , and a net purchase of 5,000 shares made by Wendye Robbins .

In summary, during the past 3 months, insiders sold 0 shares of RAPT Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,640 shares of RAPT Therapeutics Inc () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 40,640 shares.

RAPT Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

RAPT Therapeutics Inc Insider Transactions

No Available Data

Peter Svennilson Mailing Address

Above is the net worth, insider trading, and ownership report for Peter Svennilson. You might contact Peter Svennilson via mailing address: 1700 Owens Street, Suite 500, San Francisco Ca 94158.

Discussions on Peter Svennilson

No discussions yet.